Abstract
The absence of effective and satisfactory treatments that contribute to repairing the dopaminergic damage caused by Parkinson’s Disease (PD) and the limited recovery capacity of the nervous system are troubling issues and the focus of many research and clinical domains. Recent advances in the treatment of PD through stem cell (SC) therapy have recognized their promising restorative and neuroprotective effects that are implicated in the potentiation of endogenous mechanisms of repair and contribute to functional locomotor improvement. Physical exercise (PE) has been considered an adjuvant intervention that by itself induces beneficial effects in patients and animal models with Parkinsonism. In this sense, the combination of both therapies could provide synergic or superior effects for motor recovery, in contrast with their individual use. This review aims to provide an update on recent progress and the potential effectiveness of SC transplantation and PE for the treatment of locomotor deficits in PD. It has reviewed the neuropathological pathways involved in the classical motor symptoms of this condition and the mechanisms of action described in experimental studies that are associated with locomotor enhancement through exercise, cellular transplantation, and their union in some neurodegenerative conditions.
Similar content being viewed by others
Abbreviations
- PD:
-
Parkinson Disease
- PE:
-
Physical Exercise
- SCs:
-
Stem Cells
References
Elbaz, A., Carcaillon, L., Kab, S., & Moisan, F. (2016). Epidemiology of Parkinson’s disease. Revue Neurologique, 172(1), 14–26. https://doi.org/10.1016/j.neurol.2015.09.012.
Soundy, A., Stubbs, B., & Roskell, C. (2014). The experience of Parkinson’s disease: a systematic review and meta-ethnography. The Scientific World Journal, 2014, 19. https://doi.org/10.1155/2014/613592.
Kowal, S. L., Dall, T. M., Chakrabarti, R., Storm, M. V., & Jain, A. (2013). The current and projected economic burden of Parkinson’s disease in the United States. Movement Disorders, 28(3), 311–318. https://doi.org/10.1002/mds.25292.
Lindgren, P., von Campenhausen, S., Spottke, E., Siebert, U., & Dodel, R. (2005). Cost of Parkinson’s disease in Europe. European Journal of Neurology, 12(s1), 68–73. https://doi.org/10.1111/j.1468-1331.2005.01197.x.
Ferreira, D. P. C., das Graças Wanderley de Sales Coriolano, M., & dos Santos Accioly Lins, C. C. (2017). The perspective of caregivers of people with Parkinson’s: an integrative review. Revista Brasileira de Geriatria e Gerontologia, 20(1), 99–109. https://doi.org/10.1590/1981-22562017020.160088.
Schapira, A. H. V., Olanow, C. W., Greenamyre, J. T., & Bezard, E. (2014). Slowing of neurodegeneration in Parkinson’s disease and Huntington’s disease: future therapeutic perspectives. Lancet, 384(9942), 545–555. https://doi.org/10.1016/S0140-6736(14)61010-2.
Fu, M.-H., Li, C.-L., Lin, H.-L., Chen, P.-C., Calkins, M. J., Chang, Y.-F., & Yang, S.-H. (2015). Stem cell transplantation therapy in Parkinson’s disease. SpringerPlus, 4, 597. https://doi.org/10.1186/s40064-015-1400-1.
Lunn, J. S., Sakowski, S. A., Hur, J., & Feldman, E. L. (2011). Stem cell technology for neurodegenerative diseases. Annals of Neurology, 70(3), 353–361. https://doi.org/10.1002/ana.22487.
Ang, E.-T., Tai, Y.-K., Lo, S.-Q., Seet, R., & Soong, T.-W. (2010). Neurodegenerative diseases: exercising toward neurogenesis and neuroregeneration. Frontiers in Aging Neuroscience, 2, 25. https://doi.org/10.3389/fnagi.2010.00025.
Grealish, S., Diguet, E., Kirkeby, A., Mattsson, B., Heuer, A., Bramoulle, Y., & Parmar, M. (2014). Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson’s disease. Cell Stem Cell, 15(5), 653–665. https://doi.org/10.1016/j.stem.2014.09.017.
Morberg, B. M., Jensen, J., Bode, M., & Wermuth, L. (2014). The impact of high intensity physical training on motor and non-motor symptoms in patients with Parkinson’s disease (PIP): a preliminary study. NeuroRehabilitation, 35(2), 291–298. https://doi.org/10.3233/NRE-141119.
Smith, P. F. (2008). Inflammation in Parkinson’s disease: an update. Current Opinion in Investigational Drugs (London, England: 2000), 9(5), 478–484. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18465657.
Reeve, A., Simcox, E., & Turnbull, D. (2014). Ageing and Parkinson’s disease: why is advancing age the biggest risk factor? Ageing Research Reviews, 14, 19–30. https://doi.org/10.1016/j.arr.2014.01.004.
Martins-Branco, D., Esteves, A. R., Santos, D., Arduino, D. M., Swerdlow, R. H., Oliveira, C. R., & Cardoso, S. M. (2012). Ubiquitin proteasome system in Parkinson’s disease: a keeper or a witness? Experimental Neurology, 238(2), 89–99. https://doi.org/10.1016/j.expneurol.2012.08.008.
Lim, K.-L., & Tan, J. M. (2007). Role of the ubiquitin proteasome system in Parkinson’s disease. BMC Biochemistry, 8(Suppl 1), S13. https://doi.org/10.1186/1471-2091-8-S1-S13.
Dickson, D. W. (2012). Parkinson’s disease and parkinsonism: neuropathology. Cold Spring Harbor Perspectives in Medicine, 2(8), a009258. https://doi.org/10.1101/cshperspect.a009258.
Abeliovich, A., & Gitler, A. D. (2016). Defects in trafficking bridge Parkinson’s disease pathology and genetics. Nature, 539(7628), 207–216. https://doi.org/10.1038/nature20414.
Visanji, N. P., Brooks, P. L., Hazrati, L.-N., & Lang, A. E. (2013). The prion hypothesis in Parkinson’s disease: Braak to the future. Acta Neuropathologica Communications, 1, 2. https://doi.org/10.1186/2051-5960-1-2.
Esteves, A. R. F., Domingues, A. F., Ferreira, I. L., Januário, C., Swerdlow, R. H., Oliveira, C. R., & Cardoso, S. M. (2008). Mitochondrial function in Parkinson’s disease cybrids containing an nt2 neuron-like nuclear background. Mitochondrion, 8(3), 219–228. https://doi.org/10.1016/j.mito.2008.03.004.
Moon, H. E., & Paek, S. H. (2015). Mitochondrial dysfunction in Parkinson’s disease. Experimental Neurobiology, 24(2), 103–116. https://doi.org/10.5607/en.2015.24.2.103.
Kelly, N. A., Ford, M. P., Standaert, D. G., Watts, R. L., Bickel, C. S., Moellering, D. R., … Bamman, M. M. (2014). Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson’s disease. Journal of Applied Physiology, 116(5), 582–592. https://doi.org/10.1152/japplphysiol.01277.2013.
Russell, A. P., Foletta, V. C., Snow, R. J., & Wadley, G. D. (2014). Skeletal muscle mitochondria: a major player in exercise, health and disease. Biochimica et Biophysica Acta, 1840(4), 1276–1284. https://doi.org/10.1016/j.bbagen.2013.11.016.
Niedzielska, E., Smaga, I., Gawlik, M., Moniczewski, A., Stankowicz, P., Pera, J., & Filip, M. (2016). Oxidative stress in neurodegenerative diseases. Molecular Neurobiology, 53(6), 4094–4125. https://doi.org/10.1007/s12035-015-9337-5.
Wang, Q., Liu, Y., & Zhou, J. (2015). Neuroinflammation in Parkinson’s disease and its potential as therapeutic target. Translational Neurodegeneration, 4, 19. https://doi.org/10.1186/s40035-015-0042-0.
Kones, R. (2010). Parkinson’s disease: mitochondrial molecular pathology, inflammation, statins, and therapeutic neuroprotective nutrition. Nutrition in Clinical Practice, 25(4), 371–389. https://doi.org/10.1177/0884533610373932.
Qian, L., Flood, P. M., & Hong, J.-S. (2010). Neuroinflammation is a key player in Parkinson’s disease and a prime target for therapy. Journal of Neural Transmission, 117(8), 971–979. https://doi.org/10.1007/s00702-010-0428-1.
Williams, D. R., & Litvan, I. (2013). Parkinsonian syndromes. Continuum: Lifelong Learning in Neurology, 19(5 Movement Disorders), pp. 1189–1212. https://doi.org/10.1212/01.CON.0000436152.24038.e0.
Helmich, R. C., Hallett, M., Deuschl, G., Toni, I., & Bloem, B. R. (2012). Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain, 135(11), 3206–3226. https://doi.org/10.1093/brain/aws023.
Helmich, R. C., Janssen, M. J. R., Oyen, W. J. G., Bloem, B. R., & Toni, I. (2011). Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor. Annals of Neurology, 69(2), 269–281. https://doi.org/10.1002/ana.22361.
Lauzé, M., Daneault, J.-F., & Duval, C. (2016). The effects of physical activity in Parkinson’s disease: a review. Journal of Parkinson’s Disease, 6(4), 685–698. https://doi.org/10.3233/JPD-160790.
Espay, A. J., Beaton, D. E., Morgante, F., Gunraj, C. A., Lang, A. E., & Chen, R. (2009). Impairments of speed and amplitude of movement in Parkinson’s disease: a pilot study. Movement Disorders, 24, 1001–1008. https://doi.org/10.1002/mds.22480.
Cano-de-la-Cuerda, R., Pérez-de-Heredia, M., Miangolarra-Page, J. C., Muñoz-Hellín, E., & Fernández-de-las-Peñas, C. (2010). Is there muscular weakness in Parkinsonʼs disease? American Journal of Physical Medicine & Rehabilitation, 89(1), 70–76. https://doi.org/10.1097/PHM.0b013e3181a9ed9b.
Magrinelli, F., Picelli, A., Tocco, P., Federico, A., Roncari, L., Smania, N., … Tamburin, S. (2016). Pathophysiology of motor dysfunction in Parkinson’s disease as the rationale for drug treatment and rehabilitation. Parkinson’s Disease, 2016, 1–18. https://doi.org/10.1155/2016/9832839.
Ding, X., Li, Y., Liu, Z., Zhang, J., Cui, Y., Chen, X., & Chopp, M. (2013). The sonic hedgehog pathway mediates brain plasticity and subsequent functional recovery after bone marrow stromal cell treatment of stroke in mice. Journal of Cerebral Blood Flow & Metabolism, 33(7), 1015–1024. https://doi.org/10.1038/jcbfm.2013.50.
Takakusaki, K. (2017). Functional neuroanatomy for posture and gait control. Journal of Movement Disorders, 10(1), 1–17. https://doi.org/10.14802/jmd.16062.
Madrazo, I., León, V., Torres, C., Aguilera, M. C., Varela, G., Alvarez, F., & Skurovich, M. (1988). Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson’s disease. New England Journal of Medicine, 318(1), 51–51. https://doi.org/10.1056/NEJM198801073180115.
Boronat-García, A., Guerra-Crespo, M., & Drucker-Colín, R. (2017). Historical perspective of cell transplantation in Parkinson’s disease. World Journal of Transplantation, 7(3), 179. https://doi.org/10.5500/wjt.v7.i3.179.
Han, F., Baremberg, D., Gao, J., Duan, J., Lu, X., Zhang, N., & Chen, Q. (2015). Development of stem cell-based therapy for Parkinson’s disease. Translational Neurodegeneration, 4(1), 16. https://doi.org/10.1186/s40035-015-0039-8.
Lindvall, O., & Kokaia, Z. (2006). Stem cells for the treatment of neurological disorders. Nature, 441(7097), 1094–1096. https://doi.org/10.1038/nature04960.
Wang, X. H., Lu, G., Hu, X., Tsang, K. S., Kwong, W. H., Wu, F. X., … Poon, W. S. (2012). Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson’s disease. BMC Neuroscience, 13, 142. https://doi.org/10.1186/1471-2202-13-142.
Ager, R. R., Davis, J. L., Agazaryan, A., Benavente, F., Poon, W. W., LaFerla, F. M., & Blurton-Jones, M. (2015). Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer’s disease and neuronal loss. Hippocampus, 25(7), 813–826. https://doi.org/10.1002/hipo.22405.
Kempermann, G., Song, H., & Gage, F. H. (2015). Neurogenesis in the adult hippocampus. Cold Spring Harbor Perspectives in Biology, 7(9), a018812. https://doi.org/10.1101/cshperspect.a018812.
Lindvall, O., Kokaia, Z., & Martinez-Serrano, A. (2004). Stem cell therapy for human neurodegenerative disorders-how to make it work. Nature Medicine, 10 Suppl, S42–50. https://doi.org/10.1038/nm1064.
Park, D., Yang, G., Bae, D. K., Lee, S. H., Yang, Y.-H., Kyung, J., & Kim, Y.-B. (2013). Human adipose tissue-derived mesenchymal stem cells improve cognitive function and physical activity in ageing mice. Journal of Neuroscience Research, 91(5), 660–670. https://doi.org/10.1002/jnr.23182.
Feng, Z., & Gao, F. (2012). Stem cell challenges in the treatment of neurodegenerative disease. CNS Neuroscience & Therapeutics, 18(2), 142–148. https://doi.org/10.1111/j.1755-5949.2011.00239.x.
Li, R. (2012). Stem cell transplantation for treating Parkinson’s disease: literature analysis based on the web of science. Neural Regeneration Research, 7(16), 1272–1279. https://doi.org/10.3969/j.issn.1673-5374.2012.16.010.
Gerlach, M., Braak, H., Hartmann, A., Jost, W. H., Odin, P., Priller, J., & Schwarz, J. (2002). Current state of stem cell research for the treatment of Parkinson’s disease. Journal of Neurology, 249 Suppl III, 33–35. https://doi.org/10.1007/s00415-002-1307-y.
Mercanti, G., Bazzu, G., & Giusti, P. (2012). A 6-hydroxydopamine in vivo model of Parkinson’s disease. In S. Skaper (Ed.) Neurotrophic factors. Methods in Molecular Biology (Methods and Protocols), Vol. 846. Humana Press.
Glavaski-Joksimovic, A., & Bohn, M. C. (2013). Mesenchymal stem cells and neuroregeneration in Parkinson’s disease. Experimental Neurology, 247, 25–38. https://doi.org/10.1016/j.expneurol.2013.03.016.
Kitada, M., & Dezawa, M. (2012). Parkinson’s disease and mesenchymal stem cells: potential for cell-based therapy. Parkinson’s Disease, 2012, 1–9. https://doi.org/10.1155/2012/873706.
Jin, G., Cho, S., Choi, E., Lee, Y., Yu, X., Choi, K., & Kong, I. (2008). Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro. Cell Biology International, 32(11), 1433–1438. https://doi.org/10.1016/j.cellbi.2008.08.014.
Muramatsu, S.-I., Okuno, T., Suzuki, Y., Nakayama, T., Kakiuchi, T., Takino, N., & Tsukada, H. (2009). Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson’s disease. Synapse, 63(7), 541–548. https://doi.org/10.1002/syn.20634.
Bjugstad, K. B., Teng, Y. D., Redmond, D. E., Elsworth, J. D., Roth, R. H., Cornelius, S. K., … Snyder, E. Y. (2008). Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson’s disease. Experimental Neurology, 211(2), 362–369. https://doi.org/10.1016/j.expneurol.2008.01.025.
Gincberg, G., Arien-Zakay, H., Lazarovici, P., & Lelkes, P. I. (2012). Neural stem cells: therapeutic potential for neurodegenerative diseases. British Medical Bulletin, 104(1), 7–19. https://doi.org/10.1093/bmb/lds024.
Zhang, J.-M., & An, J. (2007). Cytokines, inflammation and pain. International Anesthesiology Clinics, 45(2), 27–37. https://doi.org/10.1097/AIA.0b013e318034194e.
Marks, W. J., Ostrem, J. L., Verhagen, L., Starr, P. A., Larson, P. S., Bakay, R. A., … Bartus, R. T. (2008). Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson’s disease: an open-label, phase I trial. The Lancet Neurology, 7(5), 400–408. https://doi.org/10.1016/S1474-4422(08)70065-6.
Mittermeyer, G., Christine, C. W., Rosenbluth, K. H., Baker, S. L., Starr, P., Larson, P., … Bankiewicz, K. S. (2012). Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson’s disease. Human Gene Therapy, 23(4), 377–381. https://doi.org/10.1089/hum.2011.220.
Venkataramana, N. K., Kumar, S. K. V., Balaraju, S., Radhakrishnan, R. C., Bansal, A., Dixit, A., … Totey, S. M. (2010). Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson’s disease. Translational Research, 155(2), 62–70. https://doi.org/10.1016/j.trsl.2009.07.006.
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., … Fahn, S. (2001). Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. New England Journal of Medicine, 344(10), 710–719. https://doi.org/10.1056/NEJM200103083441002.
Piccini, P., Brooks, D. J., Björklund, A., Gunn, R. N., Grasby, P. M., Rimoldi, O., … Lindvall, O. (1999). Dopamine release from nigral transplants visualized in vivo in a Parkinson’s patient. Nature Neuroscience, 2(12), 1137–1140. https://doi.org/10.1038/16060.
Kefalopoulou, Z., Politis, M., Piccini, P., Mencacci, N., Bhatia, K., Jahanshahi, M., … Foltynie, T. (2014). Long-term clinical outcome of fetal cell transplantation for Parkinson disease. JAMA Neurology, 71(1), 83. https://doi.org/10.1001/jamaneurol.2013.4749.
Piccini, P., Pavese, N., Hagell, P., Reimer, J., Björklund, A., Oertel, W. H., … Lindvall, O. (2005). Factors affecting the clinical outcome after neural transplantation in Parkinson’s disease. Brain, 128(12), 2977–2986. https://doi.org/10.1093/brain/awh649.
Stoker, T. B., Blair, N. F., & Barker, R. A. (2017). Neural grafting for Parkinson’s disease: challenges and prospects. Neural Regeneration Research. https://doi.org/10.4103/1673-5374.202935.
Marędziak, M., Marycz, K., Tomaszewski, K. A., Kornicka, K., & Henry, B. M. (2016). The influence of aging on the regenerative potential of human adipose derived mesenchymal stem cells. Stem Cells International, 2016, 2152435. https://doi.org/10.1155/2016/2152435.
Voelcker-Rehage, C., & Niemann, C. (2013). Structural and functional brain changes related to different types of physical activity across the life span. Neuroscience & Biobehavioral Reviews, 37(9), 2268–2295. https://doi.org/10.1016/j.neubiorev.2013.01.028.
Hayes, S. M., Hayes, J. P., Cadden, M., & Verfaellie, M. (2013). A review of cardiorespiratory fitness-related neuroplasticity in the aging brain. Frontiers in Aging Neuroscience, 5, 31. https://doi.org/10.3389/fnagi.2013.00031.
Svensson, M., Lexell, J., & Deierborg, T. (2015). Effects of physical exercise on neuroinflammation, neuroplasticity, neurodegeneration, and behavior. Neurorehabilitation and Neural Repair, 29(6), 577–589. https://doi.org/10.1177/1545968314562108.
Erickson, K. I., Leckie, R. L., & Weinstein, A. M. (2014). Physical activity, fitness, and gray matter volume. Neurobiology of Aging, 35, S20–S28. https://doi.org/10.1016/j.neurobiolaging.2014.03.034.
de Salles, B. F., Simão, R., Fleck, S. J., Dias, I., Kraemer-Aguiar, L. G., & Bouskela, E. (2010). Effects of resistance training on cytokines. International Journal of Sports Medicine, 31(7), 441–450. https://doi.org/10.1055/s-0030-1251994.
Calle, M. C., & Fernandez, M. L. (2010). Effects of resistance training on the inflammatory response. Nutrition Research and Practice, 4(4), 259–269. https://doi.org/10.4162/nrp.2010.4.4.259.
Oliveira, S. L. B., Pillat, M. M., Cheffer, A., Lameu, C., Schwindt, T. T., & Ulrich, H. (2013). Functions of neurotrophins and growth factors in neurogenesis and brain repair. Cytometry Part A, 83A(1), 76–89. https://doi.org/10.1002/cyto.a.22161.
Marycz, K., Mierzejewska, K., Śmieszek, A., Suszynska, E., Malicka, I., Kucia, M., & Ratajczak, M. Z. (2016). Endurance exercise mobilizes developmentally early stem cells into peripheral blood and increases their number in bone marrow: implications for tissue regeneration. Stem Cells International. https://doi.org/10.1155/2016/5756901.
Chen, W.-W., Zhang, X., & Huang, W.-J. (2016). Role of physical exercise in Alzheimer’s disease. Biomedical Reports, 4(4), 403–407. https://doi.org/10.3892/br.2016.607.
Aguiar, A. S., Castro, A. A., Moreira, E. L., Glaser, V., Santos, A. R. S., Tasca, C. I., … Kramer, A. (2011). Short bouts of mild-intensity physical exercise improve spatial learning and memory in aging rats: involvement of hippocampal plasticity via AKT, CREB and BDNF signaling. Mechanisms of Ageing and Development, 132(11–12), 560–567. https://doi.org/10.1016/j.mad.2011.09.005.
Tuon, T., Souza, P. S., Santos, M. F., et al. (2015). Physical training regulates mitochondrial parameters and neuroinflammatory mechanisms in an experimental model of Parkinson’s disease. Oxidative Medicine and Cellular Longevity, 2015, 10. https://doi.org/10.1155/2015/261809.
Corona, J. C., & Duchen, M. R. (2015). PPARγ and PGC-1α as therapeutic targets in Parkinson’s. Neurochemical Research, 40(2), 308–316. https://doi.org/10.1007/s11064-014-1377-0.
Lau, Y.-S., Patki, G., Das-Panja, K., Le, W.-D., & Ahmad, S. O. (2011). Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration. The European Journal of Neuroscience, 33(7), 1264–1274. https://doi.org/10.1111/j.1460-9568.2011.07626.x.
Ahlskog, J. E. (2011). Does vigorous exercise have a neuroprotective effect in Parkinson disease? Neurology, 77(3), 288–294. https://doi.org/10.1212/WNL.0b013e318225ab66.
Barber-Singh, J., Seo, B. B., Nakamaru-Ogiso, E., Lau, Y. S., Matsuno-Yagi, A., & Yagi, T. (2009). Neuroprotective effect of long-term NDI1 gene expression in a chronic mouse model of Parkinson disorder. Rejuvenation Research, 12, 259–267.
Phillips, C., Baktir, M. A., Srivatsan, M., & Salehi, A. (2014). Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling. Frontiers in Cellular Neuroscience, 8, 170. https://doi.org/10.3389/fncel.2014.00170.
Tambosco, L., Percebois-Macadré, L., Rapin, A., Nicomette-Bardel, J., & Boyer, F.-C. (2014). Effort training in Parkinson’s disease: a systematic review. Annals of Physical and Rehabilitation Medicine, 57(2), 79–104. https://doi.org/10.1016/j.rehab.2014.01.003.
Xu, Q., Park, Y., Huang, X., Hollenbeck, A., Blair, A., Schatzkin, A., & Chen, H. (2010). Physical activities and future risk of Parkinson disease. Neurology, 75(4), 341–348. https://doi.org/10.1212/WNL.0b013e3181ea1597.
Wu, S.-Y., Wang, T.-F., Yu, L., Jen, C. J., Chuang, J.-I., Wu, F.-S., … Kuo, Y.-M. (2011). Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway. Brain, Behavior, and Immunity, 25(1), 135–146. https://doi.org/10.1016/j.bbi.2010.09.006.
Robertson, C. L., Ishibashi, K., Chudzynski, J., Mooney, L. J., Rawson, R. A., Dolezal, B. A., … London, E. D. (2016). Effect of exercise training on striatal dopamine D2/D3 receptors in methamphetamine users during behavioral treatment. Neuropsychopharmacology, 41, 1629–1636. https://doi.org/10.1038/npp.2015.331.
Vučković, M. G., Li, Q., Fisher, B., Nacca, A., Leahy, R. M., Walsh, J. P., … Petzinger, G. M. (2010). Exercise elevates dopamine D2 receptor in a mouse model of Parkinson’s disease: in vivo imaging with [18F]Fallypride. Movement Disorders, 25(16), 2777–2784. https://doi.org/10.1002/mds.23407.
Borrione, P., Tranchita, E., Sansone, P., & Parisi, A. (2014). Effects of physical activity in Parkinson’s disease: a new tool for rehabilitation. World Journal of Methodology, 4(3), 133. https://doi.org/10.5662/wjm.v4.i3.133.
Morgan, J. A., Corrigan, F., & Baune, B. T. (2015). Effects of physical exercise on central nervous system functions: a review of brain region specific adaptations. Journal of Molecular Psychiatry, 3, 3. https://doi.org/10.1186/s40303-015-0010-8.
VanLeeuwen, J.-E., Petzinger, G. M., Walsh, J. P., Akopian, G. K., Vuckovic, M., & Jakowec, M. W. (2010). Altered AMPA receptor expression with treadmill exercise in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. Journal of Neuroscience Research, 88, 650–668. https://doi.org/10.1002/jnr.22216.
Frazzitta, G., Balbi, P., Maestri, R., Bertotti, G., Boveri, N., & Pezzoli, G. (2013). The beneficial role of intensive exercise on Parkinson disease progression. American Journal of Physical Medicine & Rehabilitation, 92(6), 523–532. https://doi.org/10.1097/PHM.0b013e31828cd254.
Rojas Vega, S., Knicker, A., Hollmann, W., Bloch, W., & Strüder, H. K. (2010). Effect of resistance exercise on serum levels of growth factors in humans. Hormone and Metabolic Research, 42(13), 982–986. https://doi.org/10.1055/s-0030-1267950.
Seo, J. H., & Cho, S.-R. (2012). Neurorestoration induced by mesenchymal stem cells: potential therapeutic mechanisms for clinical trials. Yonsei Medical Journal, 53(6), 1059–1067. https://doi.org/10.3349/ymj.2012.53.6.1059.
Sadan, O., Shemesh, N., Barzilay, R., Dadon-Nahum, M., Blumenfeld-Katzir, T., Assaf, Y., … Offen, D. (2012). Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington’s disease. Experimental Neurology, 234(2), 417–427. https://doi.org/10.1016/j.expneurol.2011.12.045.
Petzinger, G. M., Fisher, B. E., McEwen, S., Beeler, J. A., Walsh, J. P., & Jakowec, M. W. (2013). Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson’s disease. The Lancet Neurology, 12(7), 716–726. https://doi.org/10.1016/S1474-4422(13)70123-6.
Yau, S., Gil-Mohapel, J., Christie, B. R., & So, K. (2014). Physical exercise-induced adult neurogenesis: a good strategy to prevent cognitive decline in neurodegenerative diseases? BioMed Research International, 2014, 403120. https://doi.org/10.1155/2014/403120.
Sinelnyk, A. A., Klunnyk, M. O., Demchuk, M. P., Sych, N. S., Ivankova, O. V., et al. (2015) Combined therapy using fetal stem cells and a complex of physical exercises in treatment of patients with amyotrophic lateral sclerosis. Integrative Molecular Medicine 2. https://doi.org/10.15761/IMM.1000178.
Kim, Y.-M., Seo, T.-B., Kim, C.-J., & Ji, E.-S. (2017). Treadmill exercise with bone marrow stromal cells transplantation potentiates recovery of locomotor function after spinal cord injury in rats. Journal of Exercise Rehabilitation, 13(3), 273–278. https://doi.org/10.12965/jer.1735014.507.
Nicola, F. C., Rodrigues, L. P., Crestani, T., Quintiliano, K., Sanches, E. F., Willborn, S., … Netto, C. A. (2016). Human dental pulp stem cells transplantation combined with treadmill training in rats after traumatic spinal cord injury. Brazilian Journal of Medical and Biological Research, 49(9). https://doi.org/10.1590/1414-431X20165319.
Wang, J., Yang, C.-C., Chen, S.-C., & Hsieh, Y.-L. (2010). No synergistic effect of mesenchymal stem cells and exercise on functional recovery following sciatic nerve transection. Functional Neurology, 25(1), 33–43. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20626995.
Swain, R. A., Berggren, K. L., Kerr, A. L., Patel, A., Peplinski, C., & Sikorski, A. M. (2012). On aerobic exercise and behavioral and neural plasticity. Brain Sciences, 2(4), 709–744. https://doi.org/10.3390/brainsci2040709.
Murray, D. K., Sacheli, M. A., Eng, J. J., & Stoessl, A. J. (2014). The effects of exercise on cognition in Parkinson’s disease: a systematic review. Translational Neurodegeneration, 3, 5. https://doi.org/10.1186/2047-9158-3-5.
Gallaway, P. J., Miyake, H., Buchowski, M. S., Shimada, M., Yoshitake, Y., Kim, A. S., & Hongu, N. (2017). Physical activity: a viable way to reduce the risks of mild cognitive impairment, Alzheimer’s disease, and vascular dementia in older adults. Brain Sciences, 7(2). https://doi.org/10.3390/brainsci7020022.
Wildes, T. M., Stirewalt, D. L., Medeiros, B., & Hurria, A. (2014). Hematopoietic stem cell transplantation for hematologic malignancies in older adults: geriatric principles in the transplant clinic. Journal of the National Comprehensive Cancer Network: JNCCN, 12(1), 128–136. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24453296.
Hacker, E. D., Larson, J. L., & Peace, D. (2011). Exercise in patients receiving hematopoietic stem cell transplantation: lessons learned and results from a feasibility study. Oncology Nursing Forum, 38(2), 216–223. https://doi.org/10.1188/11.ONF.216-223.
Persoon, S., Kersten, M. J., van der Weiden, K., Buffart, L. M., Nollet, F., Brug, J., & Chinapaw, M. J. M. (2013). Effects of exercise in patients treated with stem cell transplantation for a hematologic malignancy: a systematic review and meta-analysis. Cancer Treatment Reviews, 39(6), 682–690. https://doi.org/10.1016/j.ctrv.2013.01.001.
Persoon, S., ChinAPaw, M. J. M., Buffart, L. M., Liu, R. D. K., Wijermans, P., Koene, H. R., … Kersten, M. J. (2017). Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: results from the EXIST study. PloS One, 12(7), e0181313. https://doi.org/10.1371/journal.pone.0181313.
Acknowledgements
Jenny Paola Berrío acknowledges the financial assistance to (CAPES) Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The Authors declare no potential conflicts of interest.
Rights and permissions
About this article
Cite this article
Hurtado, J.D.C., Sánchez, J.P.B., Nunes, R.B. et al. Stem Cell Transplantation and Physical Exercise in Parkinson’s Disease, a Literature Review of Human and Animal Studies. Stem Cell Rev and Rep 14, 166–176 (2018). https://doi.org/10.1007/s12015-017-9798-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-017-9798-1